Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 15 hours ago Drug news

Positive top-line results from Epsolay phase III program in papulopustular rosacea.- Sol-Gel Technologies Ltd.

Sol-Gel Technologies, Ltd. announced positive results from its Phase III program evaluating Epsolay (microencapsulated benzoyl peroxide cream, 5%), made with...

Added 15 hours ago Drug news

Complete Response for EM 100 an OTC eyedrop to treat ocular itching.-Eton Pharma + Bausch Health Companies

Eton Pharmaceuticals, Inc announced that the FDA provided Eton’s partner, Bausch Health Companies, with a Complete Response Letter relating to...

Added 1 day ago Drug news

BioMarin plans regulatory submissions for valoctocogene roxaparvovec to treat severe hemophilia A in 4Q 2019 in both U.S. and Europe

BioMarin Pharmaceutical Inc.announced that based on recent meetings with health authorities in the U.S. and Europe, the company plans to...

Added 2 days ago Drug news

Actinium Pharma highlights two presentations at the Health Physics Society annual meeting supporting the safety profile of Iomab-B for SIERRA trial caregivers

Actinium Pharmaceuticals, Inc. highlighted its presence at the Health Physics Society ("HPS") 64th Annual Meeting that is being held July...

Added 2 days ago Drug news

Post-hoc analyses of phase III pivotal studies of Emgality show improvements in daily functioning and reductions in disability in patients with chronic and episodic migraine

Eli Lilly and Company announced the presentation of post-hoc analyses showing improvements in daily functioning and reductions in disability in...

Added 3 days ago Drug news

FDA approves Alinity sSystem for blood and plasma screening

Abbott announced FDA approval for its new blood and plasma screening Alinity sSystem. This new solution will bring the latest...

Added 2 days ago Drug news

Positive phase III data for Emgality for episodic cluster headache is published in NEJM

Eli Lilly and Company announced that the New England Journal of Medicine published positive Phase III study results of Emgality...

Added 2 days ago Drug news

NICE gives positive recommendation of Skyrizi for psoriasis in final guidance

The National Institute for Health and Care Excellence (NICE) has published a positive Final Appraisal Document (FAD), confirming that Skyrizi...

Added 2 days ago Drug news

Subcutaneous Darzalex filed with FDA for multiple myeloma

Janssen Biotech has submitted a Biologics License Application (BLA) to the FDA for the subcutaneous delivery of Darzalex (daratumumab) for...

Added 3 days ago Drug news

MediciNova announces phase III clinical trial plan for MN 166 (ibudilast) in progressive MS

MediciNova, Inc.,announced its plans for a Phase III clinical trial of MN 166 (ibudilast) in progressive multiple sclerosis (progressive MS)...

Search all news articles